Skip to main content

Table 2 Characteristics of patients with nephrotic syndrome and healthy controls

From: Alteration of histone H3K4 methylation in glomerular podocytes associated with proteinuria in patients with membranous nephropathy

Case

Age

Sex

sCre

M-Alb/cre (mg/g cre)

HT

Duration of disease prior to biopsy (months)

Hematuria

Previous Treatment

FGS 1

45

M

0.61

6087

+

1

2+

ARB

Statin

FGS 2

47

M

3.50

4338

+

12

1+

ARB

CCB

statin

MC 1

24

M

0.71

3376

-

1

2+

-

MC 2

27

M

0.65

2868

-

1

1+

-

Amy1

73

M

0.83

4680

-

4

1+

-

Amy 2

82

F

0.65

5381

+

1

2+

ARB

Statin

Amy 3

72

F

0.9

3600

-

48

2+

ARB

ConB1

44

M

-

-

-

-

-

-

ConB2

66

M

-

-

-

-

-

-

ConB3

78

M

-

-

-

-

-

-

  1. sCre serum creatinine (mg/dL), ARB angiotensin II type 1 receptor blocker, CCB calcium channel blocker, MC minimal change, FGS focal segmental glomerular sclerosis, Amy AL amyloidosis, ConB1-3 three age-matched control, which were not obtained in a series of consecutive patients